Tin tức & Cập nhật

In the treatment of patients with pulmonary arterial hypertension, adding selexipag as a third medication sooner rather than later is crucial to help prevent hospitalization and disease progression, as suggested in an emulated target trial.

Researchers at the University of Hong Kong (HKU) have developed an innovative artificial intelligence (AI) assessment model that has the potential to fundamentally change the prevention and management of cardio-cerebrovascular (CCV) diseases specifically in the Chinese population.